Tranylcypromine

Generic name: Pronounced as (tran il sip' roe meen)
Brand names
  • Parnate®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/15/2017

A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as tranylcypromine during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, experts are not sure about how great this risk is and how much it should be considered in deciding whether a child or teenager should take an antidepressant. Children younger than 18 years of age should not normally take tranylcypromine, but in some cases, a doctor may decide that tranylcypromine is the best medication to treat a child's condition.

You should know that your mental health may change in unexpected ways when you take tranylcypromine or other antidepressants even if you are an adult over age 24. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor when you are unable to seek treatment on your own.

Your healthcare provider will want to see you often while you are taking tranylcypromine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.

The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with tranylcypromine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the FDA website: http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm.

No matter what your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you.

Tranylcypromine is used to treat depression in people who have not been helped by other medications. Tranylcypromine is in a class of medications called monoamine oxidase inhibitors (MAOIs). It works by increasing the amounts of certain natural substances that are needed to maintain mental balance.

Tranylcypromine comes as a tablet to take by mouth. It is usually taken twice a day. Take tranylcypromine at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take tranylcypromine exactly as directed.

Tranylcypromine may be habit-forming. Do not take a larger dose, take it more often, or take it for a longer period of time than prescribed by your doctor. Call your doctor if you find that you want to take extra medication or you notice any other unusual changes in your behavior or mood.

Your doctor will probably start you on a low dose of tranylcypromine and gradually increase your dose, not more often than once every 1-3 weeks. After your symptoms improve, your doctor will probably gradually decrease your dose of tranylcypromine.

Tranylcypromine controls the symptoms of depression but does not cure the condition. It may take 3 weeks or longer for you to feel the full benefit of tranylcypromine. Continue to take tranylcypromine even if you feel well. Do not stop taking tranylcypromine without talking to your doctor. Your doctor will probably want to decrease your dose gradually.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking tranylcypromine,

  • tell your doctor and pharmacist if you are allergic to tranylcypromine or any other medications.

  • tell your doctor if you are taking, you have recently taken, or you plan to take any of the following prescription or non-prescription medications: certain other antidepressants including amitriptyline (Elavil), amoxapine, clomipramine (Anafranil), desipramine (Norpramin), doxepin (Sinequan), imipramine (Tofranil), maprotiline, nortriptyline (Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); amphetamines such as amphetamine (in Adderall), benzphetamine (Didrex), dextroamphetamine (Dexedrine, Dextrostat, in Adderall), and methamphetamine (Desoxyn); bupropion (Wellbutrin, Zyban); buspirone (BuSpar); caffeine (No-Doz, Quick-Pep, Vivarin); cyclobenzaprine (Flexeril); dexfenfluramine (Redux) (not available in the U.S.); dextromethorphan (Robitussin, others); diuretics ('water pills'); levodopa (Larodopa, in Sinemet);medications for allergies,cough and cold symptoms, and hay fever;medications for high blood pressure such as guanethidine (Ismelin) (not available in the U.S.), methyldopa (Aldomet), and reserpine (Serpalan);medications for Parkinson's disease, anxiety, or weight loss (diet pills); medications for seizures such as carbamazepine (Tegretol); narcotic medications for pain; other MAOIs such as isocarboxazid (Marplan); pargyline (not available in the U.S.), phenelzine (Nardil), procarbazine (Matulane), and selegiline (Eldepryl); meperidine (Demerol); sedatives; selective serotonin reuptake inhibitors such as citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft);sleeping pills; tranquilizers; and medications containing alcohol (Nyquil, elixirs, others). Your doctor may tell you not to take tranylcypromine if you are taking or have recently stopped taking one or more of these medications.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, and herbal products you are taking or plan to take. Be sure to mention any of the following: disulfiram (Antabuse), doxepin cream (Zonalon), insulin and oral medications for diabetes, and medications for nausea or mental illness. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • you should know that tranylcypromine may remain in your body for several weeks after you stop taking the medication. During the first few weeks after your treatment ends, tell your doctor and pharmacist that you have recently stopped taking tranylcypromine before you start taking any new medications.

  • tell your doctor if you are taking any nutritional supplements, especially tryptophan.

  • tell your doctor if you have or have ever had high blood pressure; frequent or severe headaches; pheochromocytoma (a tumor on a small gland near the kidneys);a stroke or mini-stroke; or heart, blood vessel, or liver disease. Your doctor may tell you not to take tranylcypromine.

  • tell your doctor if you use or have ever used street drugs or have overused prescription medications. Tell your doctor if you have or have ever had anxiety, agitation, diabetes, seizures, or kidney or thyroid disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking tranylcypromine, call your doctor.

  • if you are having surgery, including dental surgery, or any x-ray procedure, tell the doctor or dentist that you are taking tranylcypromine.

  • you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication. Do not drink alcohol while you are taking tranylcypromine.

  • you should know that tranylcypromine may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking tranylcypromine. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

You may experience a serious reaction if you eat foods that are high in tyramine during your treatment with tranylcypromine. Tyramine is found in many foods, including meat, poultry, fish, or cheese that has been smoked, aged, improperly stored, or spoiled; certain fruits, vegetables, and beans; alcoholic beverages; and yeast products that have fermented. Your doctor or dietitian will tell you which foods you must avoid completely, and which foods you may eat in small amounts. You should also avoid foods and drinks that contain caffeine during your treatment with tranylcypromine. Follow these directions carefully. Ask your doctor or dietitian if you have any questions about what you may eat and drink during your treatment.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Tranylcypromine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • drowsiness

    • weakness

    • dry mouth

    • loss of appetite

    • diarrhea

    • constipation

    • stomach pain

    • blurred vision

    • chills

    • ringing in the ears

    • muscle tightening or jerking

    • uncontrollable shaking of any part of the body

    • numbness, burning, or tingling in the arms or legs

    • difficulty urinating

    • decreased sexual ability

    • hair loss

    • rash

  • Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:

    • headache

    • slow, fast, or pounding heartbeat

    • chest pain or tightness

    • tightening of the throat

    • nausea

    • sweating

    • fever

    • cold, clammy skin

    • dizziness

    • neck stiffness or soreness

    • sensitivity to light

    • widened pupils (black circles in the middle of the eyes)

    • swelling of arms, hands, feet, ankles, or lower legs

    • unusual bleeding or bruising

    • pain in the upper right part of the stomach

    • flu-like symptoms

    • yellowing of the skin or eyes

  • Tranylcypromine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • difficulty falling asleep or staying asleep

  • restlessness

  • anxiety

  • agitation

  • confusion

  • unclear speech

  • dizziness

  • weakness

  • drowsiness

  • headache

  • muscle twitching

  • fever

  • stiffness

  • coma (loss of consciousness for a period of time)

Keep all appointments with your doctor. Your doctor will check your blood pressure often during your treatment with tranylcypromine.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Transamine sulphate

Drug Interaction
Repaglinide Repaglinide Tranylcypromine may increase the hypoglycemic activities of Repaglinide.
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Tranylcypromine.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection Tranylcypromine may increase the hypoglycemic activities of Insulin glargine.
Leflunomide Leflunomide The metabolism of Leflunomide can be decreased when combined with Tranylcypromine.
Delavirdine Delavirdine The metabolism of Delavirdine can be decreased when combined with Tranylcypromine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Tranylcypromine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Tranylcypromine.
Dolasetron Dolasetron The metabolism of Dolasetron can be decreased when combined with Tranylcypromine.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Tranylcypromine.
Anagrelide Anagrelide The metabolism of Anagrelide can be decreased when combined with Tranylcypromine.
Candesartan Candesartan Tranylcypromine may increase the hypotensive activities of Candesartan.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Tranylcypromine.
Clopidogrel Clopidogrel The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Diphenoxylate.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be decreased when combined with Tranylcypromine.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Tranylcypromine.
Guanfacine Guanfacine Tranylcypromine may increase the hypotensive activities of Guanfacine.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Tranylcypromine.
Miglitol Miglitol Tranylcypromine may increase the hypoglycemic activities of Miglitol.
Naratriptan Naratriptan The metabolism of Naratriptan can be decreased when combined with Tranylcypromine.
Olsalazine Olsalazine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Olsalazine.
Paregoric Paregoric Tranylcypromine may increase the analgesic activities of Morphine.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Tranylcypromine.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Tranylcypromine.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Tranylcypromine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Reserpine.
Rizatriptan Rizatriptan The metabolism of Rizatriptan can be decreased when combined with Tranylcypromine.
Sumatriptan Sumatriptan The metabolism of Sumatriptan can be decreased when combined with Tranylcypromine.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Tranylcypromine.
Tizanidine Tizanidine The metabolism of Tizanidine can be decreased when combined with Tranylcypromine.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Tranylcypromine.
Hydromorphone Injection Hydromorphone Injection Tranylcypromine may increase the serotonergic activities of Hydromorphone.
Meperidine Injection Meperidine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Tranylcypromine is combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Tranylcypromine.
Morphine Injection Morphine Injection Tranylcypromine may increase the analgesic activities of Morphine.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Tranylcypromine.
Altretamine Altretamine Tranylcypromine may increase the hypertensive activities of Amphetamine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Tranylcypromine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Tranylcypromine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Granisetron.
Torsemide Torsemide Tranylcypromine may increase the hypotensive activities of Torasemide.
Olanzapine Olanzapine The metabolism of Tranylcypromine can be decreased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Tranylcypromine.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Tranylcypromine.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Tranylcypromine.
Eprosartan Eprosartan Tranylcypromine may increase the hypotensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Hydroxychloroquine can be decreased when combined with Tranylcypromine.
Meloxicam Meloxicam The metabolism of Meloxicam can be decreased when combined with Tranylcypromine.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Oxcarbazepine.
Pantoprazole Pantoprazole The metabolism of Pantoprazole can be decreased when combined with Tranylcypromine.
Telmisartan Telmisartan Tranylcypromine may increase the hypotensive activities of Telmisartan.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Zaleplon.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Desloratadine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Pentosan polysulfate.
Trimipramine Trimipramine The metabolism of Tranylcypromine can be decreased when combined with Trimipramine.
Glycopyrrolate Glycopyrrolate Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Perindopril Perindopril Tranylcypromine may increase the hypotensive activities of Perindopril.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Tranylcypromine.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of hypertension can be increased when Tranylcypromine is combined with Choline magnesium trisalicylate.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Tranylcypromine.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Tranylcypromine is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection Tranylcypromine may increase the hypertensive activities of Epinephrine.
Eplerenone Eplerenone Tranylcypromine may increase the hypotensive activities of Eplerenone.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Escitalopram.
Olmesartan Olmesartan Tranylcypromine may increase the hypotensive activities of Olmesartan.
Zonisamide Zonisamide The metabolism of Zonisamide can be decreased when combined with Tranylcypromine.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Tranylcypromine.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate Tranylcypromine may increase the hypertensive activities of Dexmethylphenidate.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Tranylcypromine.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Tranylcypromine.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Tranylcypromine.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Tranylcypromine.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Tranylcypromine.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Tranylcypromine.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Tranylcypromine.
Tadalafil Tadalafil Tranylcypromine may increase the hypotensive activities of Tadalafil.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Tranylcypromine.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Tranylcypromine.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Tranylcypromine.
Protriptyline Protriptyline The metabolism of Tranylcypromine can be decreased when combined with Protriptyline.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Tranylcypromine is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Tranylcypromine.
Trospium Trospium Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Tranylcypromine may increase the hypotensive activities of Bosentan.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Tranylcypromine.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Tranylcypromine.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Tranylcypromine is combined with Eszopiclone.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection Tranylcypromine may increase the hypoglycemic activities of Insulin aspart.
Solifenacin Solifenacin The metabolism of Solifenacin can be decreased when combined with Tranylcypromine.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Tranylcypromine.
Dextroamphetamine Dextroamphetamine Tranylcypromine may increase the hypertensive activities of Amphetamine.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Tranylcypromine.
Pramlintide Injection Pramlintide Injection Tranylcypromine may increase the hypoglycemic activities of Pramlintide.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Exenatide Injection Exenatide Injection Tranylcypromine may increase the hypoglycemic activities of Exenatide.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Isocarboxazid.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Tranylcypromine.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Tranylcypromine.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Tranylcypromine.
Pregabalin Pregabalin The therapeutic efficacy of Tranylcypromine can be increased when used in combination with Pregabalin.
Phenylephrine Phenylephrine Tranylcypromine may increase the hypertensive activities of Phenylephrine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Tranylcypromine.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection Tranylcypromine may increase the hypoglycemic activities of Insulin detemir.
Ranolazine Ranolazine The metabolism of Ranolazine can be decreased when combined with Tranylcypromine.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Rasagiline.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Tranylcypromine.
Sitagliptin Sitagliptin Tranylcypromine may increase the hypoglycemic activities of Sitagliptin.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Tranylcypromine.
Albuterol Albuterol The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Salbutamol.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Tranylcypromine.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Tranylcypromine.
Clofarabine Injection Clofarabine Injection Tranylcypromine may increase the orthostatic hypotensive activities of Clofarabine.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection Tranylcypromine may increase the hypoglycemic activities of Insulin glulisine.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Tranylcypromine.
Aliskiren Aliskiren Tranylcypromine may increase the hypotensive activities of Aliskiren.
Pemetrexed Injection Pemetrexed Injection The metabolism of Pemetrexed can be decreased when combined with Tranylcypromine.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine Tranylcypromine may increase the hypertensive activities of Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Tranylcypromine.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Tranylcypromine.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Tranylcypromine.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Tranylcypromine.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Tranylcypromine.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Tranylcypromine.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Tranylcypromine.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Tranylcypromine.
Bexarotene Bexarotene The metabolism of Bexarotene can be decreased when combined with Tranylcypromine.
Desmopressin Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Tranylcypromine.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Tranylcypromine.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tranylcypromine.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Tranylcypromine.
Arsenic Trioxide Injection Arsenic Trioxide Injection Tranylcypromine may increase the orthostatic hypotensive activities of Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Tranylcypromine may increase the serotonergic activities of Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Tranylcypromine.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Tranylcypromine.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Tranylcypromine.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Tranylcypromine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Tranylcypromine.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Tranylcypromine.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Tranylcypromine.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Tranylcypromine.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Tranylcypromine.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Tranylcypromine.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Tranylcypromine.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Tranylcypromine.
Milnacipran Milnacipran Tranylcypromine may increase the serotonergic activities of Milnacipran.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Tranylcypromine.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Tranylcypromine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Tranylcypromine.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Tranylcypromine.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Prasugrel.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Tranylcypromine.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Tranylcypromine.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Tranylcypromine.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Tranylcypromine.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Tranylcypromine.
Palonosetron Injection Palonosetron Injection The metabolism of Tranylcypromine can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin Tranylcypromine may increase the hypoglycemic activities of Saxagliptin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Tranylcypromine.
Tapentadol Tapentadol The risk or severity of adverse effects can be increased when Tapentadol is combined with Tranylcypromine.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Tranylcypromine.
Asenapine Asenapine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Vigabatrin.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Tranylcypromine.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Tranylcypromine.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Tranylcypromine.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Dabigatran.
Liraglutide Injection Liraglutide Injection Tranylcypromine may increase the hypoglycemic activities of Liraglutide.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Tranylcypromine is combined with Dalfampridine.
Fingolimod Fingolimod The metabolism of Fingolimod can be decreased when combined with Tranylcypromine.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Tranylcypromine.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Tranylcypromine.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection Tranylcypromine may increase the hepatotoxic activities of Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Tranylcypromine.
Denileukin Diftitox Injection Denileukin Diftitox Injection Tranylcypromine may increase the orthostatic hypotensive activities of Aldesleukin.
Terbutaline Injection Terbutaline Injection The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Terbutaline.
Azilsartan Azilsartan Tranylcypromine may increase the orthostatic hypotensive activities of Azilsartan medoxomil.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Tranylcypromine.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Tranylcypromine.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Tranylcypromine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Tranylcypromine.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Tranylcypromine.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Tranylcypromine.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Tranylcypromine.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Tranylcypromine.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Tranylcypromine.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Tranylcypromine.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Tranylcypromine.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Tranylcypromine.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Tranylcypromine.
Ambrisentan Ambrisentan Tranylcypromine may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Fondaparinux.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Tiagabine.
Iloprost Iloprost Tranylcypromine may increase the orthostatic hypotensive activities of Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Tranylcypromine.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Tranylcypromine.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Tranylcypromine.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Tranylcypromine.
Lorcaserin Lorcaserin Tranylcypromine may increase the hypoglycemic activities of Mecasermin.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Tranylcypromine.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Icosapent ethyl.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Tranylcypromine.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Tranylcypromine.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Tranylcypromine.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Tranylcypromine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Tranylcypromine.
Apixaban Apixaban The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Apixaban.
Canagliflozin Canagliflozin Tranylcypromine may increase the orthostatic hypotensive activities of Canagliflozin.
Methazolamide Methazolamide Tranylcypromine may increase the orthostatic hypotensive activities of Methazolamide.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Tranylcypromine.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Tranylcypromine.
Levomilnacipran Levomilnacipran Tranylcypromine may increase the serotonergic activities of Levomilnacipran.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Tranylcypromine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Tranylcypromine.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Tranylcypromine.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Tranylcypromine.
Ketorolac Injection Ketorolac Injection The metabolism of Tranylcypromine can be decreased when combined with Ketorolac.
Obinutuzumab Injection Obinutuzumab Injection Tranylcypromine may increase the orthostatic hypotensive activities of Obinutuzumab.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Tranylcypromine.
Apremilast Apremilast The metabolism of Apremilast can be decreased when combined with Tranylcypromine.
Droxidopa Droxidopa Tranylcypromine may increase the hypertensive activities of Droxidopa.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Tranylcypromine.
Albiglutide Injection Albiglutide Injection Tranylcypromine may increase the hypoglycemic activities of Albiglutide.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Eslicarbazepine.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Tranylcypromine.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Tranylcypromine.
Empagliflozin Empagliflozin Tranylcypromine may increase the orthostatic hypotensive activities of Empagliflozin.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Vorapaxar.
Hydrocodone Hydrocodone Tranylcypromine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection Tranylcypromine may increase the hypoglycemic activities of Dulaglutide.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Edoxaban.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Tranylcypromine.
Methamphetamine Methamphetamine Tranylcypromine may increase the hypertensive activities of Metamfetamine.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Tranylcypromine.
Riociguat Riociguat Tranylcypromine may increase the hypotensive activities of Riociguat.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Tranylcypromine.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Tranylcypromine.
Risperidone Injection Risperidone Injection Tranylcypromine may increase the hypotensive activities of Risperidone.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Tranylcypromine.
Insulin Human Inhalation Insulin Human Inhalation Tranylcypromine may increase the hypoglycemic activities of Insulin human.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Tranylcypromine.
Dinutuximab Injection Dinutuximab Injection Tranylcypromine may increase the orthostatic hypotensive activities of Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Tranylcypromine.
Amiloride Amiloride Tranylcypromine may increase the orthostatic hypotensive activities of Amiloride.
Macitentan Macitentan Tranylcypromine may increase the hypotensive activities of Macitentan.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Tranylcypromine.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Tranylcypromine.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Tranylcypromine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Tranylcypromine.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Tranylcypromine.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection Tranylcypromine may increase the hypoglycemic activities of Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Tranylcypromine.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Tranylcypromine.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Tranylcypromine.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Tranylcypromine.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Tranylcypromine.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Tranylcypromine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Tranylcypromine may increase the orthostatic hypotensive activities of Amphotericin B.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Tranylcypromine.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Tranylcypromine.
Midodrine Midodrine Tranylcypromine may increase the hypertensive activities of Midodrine.
Selexipag Selexipag Tranylcypromine may increase the hypotensive activities of Selexipag.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Tranylcypromine may increase the orthostatic hypotensive activities of Furosemide.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Tranylcypromine.
Lixisenatide Injection Lixisenatide Injection Tranylcypromine may increase the hypoglycemic activities of Lixisenatide.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Tranylcypromine.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Tranylcypromine.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Tranylcypromine.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Tranylcypromine.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Safinamide.
Midostaurin Midostaurin The metabolism of Midostaurin can be decreased when combined with Tranylcypromine.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Tranylcypromine.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Tranylcypromine.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Tranylcypromine.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Tranylcypromine.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Tranylcypromine.
Betrixaban Betrixaban The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Betrixaban.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Tranylcypromine.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Tranylcypromine.
Semaglutide Injection Semaglutide Injection Tranylcypromine may increase the hypoglycemic activities of Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Tranylcypromine may increase the hypoglycemic activities of Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Buprenorphine is combined with Tranylcypromine.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Tranylcypromine.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Tranylcypromine.
Lofexidine Lofexidine The therapeutic efficacy of Tranylcypromine can be increased when used in combination with Lofexidine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Tranylcypromine.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Tranylcypromine.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Tranylcypromine.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Tranylcypromine.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Tranylcypromine.
Eravacycline Injection Eravacycline Injection The metabolism of Eravacycline can be decreased when combined with Tranylcypromine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Tranylcypromine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tranylcypromine.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Tranylcypromine.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Tranylcypromine.
Stiripentol Stiripentol The metabolism of Stiripentol can be decreased when combined with Tranylcypromine.
Gilteritinib Gilteritinib The therapeutic efficacy of Tranylcypromine can be decreased when used in combination with Gilteritinib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Tranylcypromine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Tranylcypromine.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Tranylcypromine.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Tranylcypromine.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Tranylcypromine.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Caplacizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Tranylcypromine.
Esomeprazole Injection Esomeprazole Injection The metabolism of Esomeprazole can be decreased when combined with Tranylcypromine.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Tranylcypromine.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Tranylcypromine.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Tranylcypromine.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Tranylcypromine.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Tranylcypromine.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Tranylcypromine.
Pitolisant Pitolisant The metabolism of Pitolisant can be decreased when combined with Tranylcypromine.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Tranylcypromine.
Lefamulin Lefamulin The metabolism of Lefamulin can be decreased when combined with Tranylcypromine.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Tranylcypromine.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Tranylcypromine.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Tranylcypromine.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Tranylcypromine.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Tranylcypromine.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Lasmiditan.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Tranylcypromine.
Cenobamate Cenobamate The metabolism of Cenobamate can be decreased when combined with Tranylcypromine.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Tranylcypromine.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Tranylcypromine is combined with Selpercatinib.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Tranylcypromine.
Opicapone Opicapone The risk or severity of adverse effects can be increased when Opicapone is combined with Tranylcypromine.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Tranylcypromine is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Tranylcypromine.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Viloxazine.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Tranylcypromine.
Fenoprofen Fenoprofen The risk or severity of hypertension can be increased when Fenoprofen is combined with Tranylcypromine.
Indomethacin Indomethacin The metabolism of Indomethacin can be decreased when combined with Tranylcypromine.
Mefenamic Acid Mefenamic Acid The metabolism of Mefenamic acid can be decreased when combined with Tranylcypromine.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Tranylcypromine.
Tolmetin Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Tranylcypromine.
Sulindac Sulindac The risk or severity of hypertension can be increased when Sulindac is combined with Tranylcypromine.
Trazodone Trazodone Tranylcypromine may increase the serotonergic activities of Trazodone.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Tranylcypromine.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Tranylcypromine.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Tranylcypromine.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Tranylcypromine.
Primidone Primidone The metabolism of Primidone can be decreased when combined with Tranylcypromine.
Methsuximide Methsuximide The metabolism of Methsuximide can be decreased when combined with Tranylcypromine.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Tranylcypromine can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Diazepam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Oxazepam.
Flurazepam Flurazepam The metabolism of Tranylcypromine can be decreased when combined with Flurazepam.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Tranylcypromine.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Tranylcypromine.
Phenoxybenzamine Phenoxybenzamine Tranylcypromine may increase the hypotensive activities of Phenoxybenzamine.
Carmustine Carmustine The metabolism of Carmustine can be decreased when combined with Tranylcypromine.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Amantadine.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Tranylcypromine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Tranylcypromine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Tranylcypromine.
Bromocriptine Bromocriptine Tranylcypromine may increase the hypertensive activities of Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Orciprenaline.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Tranylcypromine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Ergoloid mesylate.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Prochlorperazine Prochlorperazine The metabolism of Tranylcypromine can be decreased when combined with Prochlorperazine.
Thioridazine Thioridazine The metabolism of Tranylcypromine can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine The risk or severity of extrapyramidal symptoms can be increased when Tranylcypromine is combined with Trifluoperazine.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Tranylcypromine.
Sulfadiazine Sulfadiazine Tranylcypromine may increase the hypoglycemic activities of Sulfadiazine.
Oxycodone Oxycodone Tranylcypromine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Tranylcypromine.
Oxybutynin Oxybutynin Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine The metabolism of Benzatropine can be decreased when combined with Tranylcypromine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Tranylcypromine.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Tranylcypromine.
Trihexyphenidyl Trihexyphenidyl Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Tranylcypromine.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Tranylcypromine.
Fluphenazine Fluphenazine The risk or severity of extrapyramidal symptoms can be increased when Fluphenazine is combined with Tranylcypromine.
Phentermine Phentermine Tranylcypromine may increase the hypertensive activities of Phentermine.
Methylphenidate Methylphenidate Tranylcypromine may increase the hypertensive activities of Methylphenidate.
Amoxapine Amoxapine The metabolism of Tranylcypromine can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Sulfasalazine.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Tranylcypromine.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tranylcypromine.
Molindone Molindone The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Molindone.
Methyldopa Methyldopa Tranylcypromine may decrease the hypotensive activities of Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Tranylcypromine.
Prazosin Prazosin Tranylcypromine may increase the hypotensive activities of Prazosin.
Hydralazine Hydralazine Tranylcypromine may increase the hypotensive activities of Hydralazine.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Tranylcypromine.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Clonazepam.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Tranylcypromine.
Promethazine Promethazine The metabolism of Promethazine can be decreased when combined with Tranylcypromine.
Meclofenamate Meclofenamate The risk or severity of hypertension can be increased when Tranylcypromine is combined with Meclofenamic acid.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Tranylcypromine.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Tranylcypromine.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Tranylcypromine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Tranylcypromine.
Triamterene Triamterene Tranylcypromine may increase the orthostatic hypotensive activities of Triamterene.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide Tranylcypromine may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone Chlorthalidone Tranylcypromine may increase the hypotensive activities of Chlorthalidone.
Metolazone Metolazone Tranylcypromine may increase the hypotensive activities of Metolazone.
Secobarbital Secobarbital Secobarbital may increase the hypotensive activities of Tranylcypromine.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Tranylcypromine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Tranylcypromine.
Imipramine Imipramine The metabolism of Tranylcypromine can be decreased when combined with Imipramine.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Tranylcypromine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Tranylcypromine.
Isoniazid Isoniazid The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Isoniazid.
Disopyramide Disopyramide The metabolism of Disopyramide can be decreased when combined with Tranylcypromine.
Valproic Acid Valproic Acid The metabolism of Tranylcypromine can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Tranylcypromine.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Tranylcypromine.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Tranylcypromine.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Tranylcypromine.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Tranylcypromine.
Dextromethorphan Dextromethorphan The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine Cyclobenzaprine may increase the serotonergic activities of Tranylcypromine.
Baclofen Baclofen The risk or severity of hypotension can be increased when Baclofen is combined with Tranylcypromine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Cyproheptadine Cyproheptadine Tranylcypromine may increase the anticholinergic activities of Cyproheptadine.
Clemastine Clemastine Tranylcypromine may increase the anticholinergic activities of Clemastine.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Tranylcypromine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Tranylcypromine.
Meclizine Meclizine The metabolism of Tranylcypromine can be decreased when combined with Meclizine.
Methyclothiazide Methyclothiazide Tranylcypromine may increase the orthostatic hypotensive activities of Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide Tranylcypromine may increase the hypotensive activities of Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Tranylcypromine.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Tranylcypromine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Tranylcypromine.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Propranolol can be increased when it is combined with Tranylcypromine.
Minoxidil Minoxidil Tranylcypromine may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Tranylcypromine may increase the hypertensive activities of Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Tranylcypromine can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone Tranylcypromine may increase the orthostatic hypotensive activities of Spironolactone.
Amphotericin B Injection Amphotericin B Injection Tranylcypromine may increase the orthostatic hypotensive activities of Amphotericin B.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Tranylcypromine.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Tranylcypromine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tranylcypromine.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Tranylcypromine.
Flavoxate Flavoxate Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine Tranylcypromine may increase the orthostatic hypotensive activities of Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Tranylcypromine.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Tranylcypromine.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Tranylcypromine.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Tranylcypromine.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Acetazolamide.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Pyrantel.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Tranylcypromine.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Tranylcypromine.
Captopril Captopril Tranylcypromine may increase the hypotensive activities of Captopril.
Dipyridamole Dipyridamole Tranylcypromine may increase the orthostatic hypotensive activities of Dipyridamole.
Isoxsuprine Isoxsuprine Tranylcypromine may increase the orthostatic hypotensive activities of Isoxsuprine.
Vinblastine Vinblastine The metabolism of Vinblastine can be decreased when combined with Tranylcypromine.
Ethacrynic Acid Ethacrynic Acid Tranylcypromine may increase the orthostatic hypotensive activities of Etacrynic acid.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Tranylcypromine.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Thiothixene.
Aspirin Aspirin The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Acetylsalicylic acid.
Salsalate Salsalate The risk or severity of hypertension can be increased when Tranylcypromine is combined with Salsalate.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Tranylcypromine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Tranylcypromine.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Triazolam.
Dicyclomine Dicyclomine Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Tranylcypromine.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Tranylcypromine.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Tranylcypromine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Tranylcypromine.
Verapamil Verapamil Tranylcypromine may increase the orthostatic hypotensive activities of Verapamil.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Tranylcypromine.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Tranylcypromine.
Diflunisal Diflunisal The risk or severity of hypertension can be increased when Tranylcypromine is combined with Diflunisal.
Piroxicam Piroxicam The metabolism of Piroxicam can be decreased when combined with Tranylcypromine.
Bumetanide Bumetanide Tranylcypromine may increase the orthostatic hypotensive activities of Bumetanide.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Tranylcypromine.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Tranylcypromine.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Tranylcypromine.
Indapamide Indapamide Tranylcypromine may increase the hypotensive activities of Indapamide.
Pentoxifylline Pentoxifylline The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Tranylcypromine.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Tranylcypromine.
Guanabenz Guanabenz Tranylcypromine may increase the hypotensive activities of Guanabenz.
Ketoprofen Ketoprofen The risk or severity of hypertension can be increased when Tranylcypromine is combined with Ketoprofen.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Tranylcypromine.
Enalapril Enalapril Tranylcypromine may increase the hypotensive activities of Enalapril.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Tranylcypromine.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Tranylcypromine.
Buspirone Buspirone The risk or severity of hypertension can be increased when Tranylcypromine is combined with Buspirone.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Tranylcypromine.
Mesalamine Mesalamine The risk or severity of hypertension can be increased when Mesalazine is combined with Tranylcypromine.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Tranylcypromine.
Fluoxetine Fluoxetine The risk or severity of serotonin syndrome can be increased when Fluoxetine is combined with Tranylcypromine.
Nimodipine Nimodipine Tranylcypromine may increase the hypotensive activities of Nimodipine.
Clozapine Clozapine The metabolism of Tranylcypromine can be decreased when combined with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Estazolam.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Tranylcypromine.
Benazepril Benazepril Tranylcypromine may increase the hypotensive activities of Benazepril.
Etodolac Etodolac The metabolism of Etodolac can be decreased when combined with Tranylcypromine.
Felodipine Felodipine Tranylcypromine may increase the hypotensive activities of Felodipine.
Fosinopril Fosinopril Tranylcypromine may increase the hypotensive activities of Fosinopril.
Nabumetone Nabumetone The metabolism of Nabumetone can be decreased when combined with Tranylcypromine.
Quinapril Quinapril Tranylcypromine may increase the hypotensive activities of Quinapril.
Ramipril Ramipril Tranylcypromine may increase the hypotensive activities of Ramipril.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Tranylcypromine.
Amlodipine Amlodipine Tranylcypromine may increase the hypotensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Tranylcypromine.
Lisinopril Lisinopril Tranylcypromine may increase the hypotensive activities of Lisinopril.
Oxaprozin Oxaprozin The risk or severity of hypertension can be increased when Tranylcypromine is combined with Oxaprozin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Tranylcypromine.
Bisoprolol Bisoprolol Tranylcypromine may increase the hypotensive activities of Bisoprolol.
Zolpidem Zolpidem Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Tranylcypromine.
Terazosin Terazosin Tranylcypromine may increase the hypotensive activities of Terazosin.
Isradipine Isradipine Tranylcypromine may increase the hypotensive activities of Isradipine.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Tranylcypromine.
Cisapride Cisapride The metabolism of Tranylcypromine can be decreased when combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Gabapentin.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Tranylcypromine.
Venlafaxine Venlafaxine The metabolism of Tranylcypromine can be decreased when combined with Venlafaxine.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Tranylcypromine.
Fluvoxamine Fluvoxamine Fluvoxamine may increase the serotonergic activities of Tranylcypromine.
Nefazodone Nefazodone Tranylcypromine may increase the serotonergic activities of Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Tranylcypromine.
Losartan Losartan Tranylcypromine may increase the hypotensive activities of Losartan.
Tramadol Tramadol The risk or severity of serotonin syndrome and seizure can be increased when Tranylcypromine is combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Tranylcypromine.
Moexipril Moexipril Tranylcypromine may increase the hypotensive activities of Moexipril.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Tranylcypromine.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Tranylcypromine.
Nicardipine Nicardipine Tranylcypromine may increase the hypotensive activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Tranylcypromine.
Metformin Metformin Tranylcypromine may increase the hypoglycemic activities of Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Dalteparin.
Nisoldipine Nisoldipine Tranylcypromine may increase the hypotensive activities of Nisoldipine.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Tranylcypromine.
Amifostine Injection Amifostine Injection Tranylcypromine may increase the orthostatic hypotensive activities of Amifostine.
Acarbose Acarbose Tranylcypromine may increase the hypoglycemic activities of Acarbose.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Tranylcypromine.
Ritonavir Ritonavir The metabolism of Tranylcypromine can be decreased when combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Tranylcypromine.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Tranylcypromine.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Tranylcypromine.
Mirtazapine Mirtazapine Tranylcypromine may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Tranylcypromine may increase the hypotensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Tranylcypromine.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Tranylcypromine.
Valsartan Valsartan Tranylcypromine may increase the hypotensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection Tranylcypromine may increase the hypoglycemic activities of Insulin lispro.
Pramipexole Pramipexole Tranylcypromine may increase the sedative activities of Pramipexole.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Tranylcypromine.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Tranylcypromine.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Tranylcypromine.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Tranylcypromine.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Tranylcypromine.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Tranylcypromine.
Sertraline Sertraline The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Sertraline.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Tranylcypromine.
Letrozole Letrozole The metabolism of Letrozole can be decreased when combined with Tranylcypromine.
Irbesartan Irbesartan Tranylcypromine may increase the hypotensive activities of Irbesartan.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Tranylcypromine.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Ropinirole.
Finasteride Finasteride The risk or severity of hypertension can be increased when Tranylcypromine is combined with Finasteride.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Tranylcypromine.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Tranylcypromine.
Paroxetine Paroxetine Paroxetine may increase the serotonergic activities of Tranylcypromine.
Tolcapone Tolcapone Tranylcypromine may increase the orthostatic hypotensive activities of Tolcapone.
Citalopram Citalopram The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Citalopram.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Tranylcypromine.
Efavirenz Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Tranylcypromine.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Tranylcypromine.
Pioglitazone Pioglitazone Tranylcypromine may increase the hypoglycemic activities of Pioglitazone.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Tranylcypromine.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Tranylcypromine.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Tranylcypromine.
Thalidomide Thalidomide Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Balsalazide Balsalazide The risk or severity of hypertension can be increased when Tranylcypromine is combined with Balsalazide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Tranylcypromine.
Galantamine Galantamine The metabolism of Galantamine can be decreased when combined with Tranylcypromine.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Levetiracetam.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Tranylcypromine.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Tranylcypromine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!